Start for free
Start for free
GB

GTC Biotherapeutics

North America, Massachusetts, United States, Framingham

Description

GTC Biotherapeutics is a developer of human therapeutic proteins in the milk of transgenic animals.

Investor Profile

GTC Biotherapeutics has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GTC Biotherapeutics frequently co-invest with?

WC
Wharton Capital
North America, New York, United States, New York
Co-Investments: 1
SD
Sorenson Development
North America, Utah, United States, Salt Lake City
Co-Investments: 1

What are some of recent deals done by GTC Biotherapeutics?

Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series CMay 5, 2004
Amount Raised: $28,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator